Methods of treating psoriasis using PD-1 binding antibodies
US10751414B2 · kind B2 · utility
8Cited by
127References
66Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 2017 |
| Grant date | Aug 25, 2020 |
| Priority date | — |
| Expiry date | Nov 18, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are methods for managing, treating, or preventing immune disorders, such as autoimmune diseases, using proteins that specifically bind to Programmed Death-1 (PD-1) and modulate the expression and/or activity of PD-1.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.